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Pretoria, where he arrived late that evening. The following morning
the Transvaal Museum confirmed that the snake was a small
boomslang, about 30 cm long and I cm in diameter. The patient
received treatment including boomslang antivenom. He made a
good recovery and was discharged on the 4th day.
It is likely that the amount of boomslang venom that enters
with a bite may be a factor in determining the time between the
bite and the onset of s~ptoms.2 J. H. R. Becker (Professor of
Surgery, University of Pretoria - personal communication) has
found that when boomslang venom is injected into experimental
animals, poisoning and death are dose-dependent, occurring rapidly
(within a few hours) when large doses are given and much later
(12 - 24 hours or more) with small doses. In the case described
above the dose would have been relatively small, since an under-
sized snake was responsible for the bite.
From this case report it may be concluded that in boomslang
bite a long time may elapse between the bite and the onset of
symptoms. It is therefore unsafe to assume that no envenomation
has occurred if a patient has shown no adverse signs or symptoms
within a few hours after a boomslang bite.
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Readers are reminded rhar rhe July issue of CME deals wirh bires,
srings and poisons. - Editor
Erratum - CME diabetes issue
To the Editor: Sulphonylurea agents prescribed for non-insulin-
dependent diabetes mellirus can cause fatal hypoglycaemia. The
risks are enhanced when the longer acting chlorpropamide and
glibenclarnide 1,2 are used, particularly in the elderly and in patients
with impaired renal function, and when maximum doses are
prescribed at the initiation of therapy.
We wish to draw readers' attention to a potentially dangerous
error in Table I (p. 426) of an article3 in the April 1989 issue of
Cominuing Medical Educarion, where the chlorpropamide and tol-
butamide doses were transposed. Table I is reprinted here with
the correct figures.
Chlorpropamide remains a popular drug world-wide because of
its low price and once-daily dose convenience. In the elderly and
in patients with impaired renal function, it can cause severe
prolonged hypoglycaemia with considerable morbidity and morta-
lity. Doctors caring for diabetic patients are urged to take note of
the error in the article mentioned. The correCl chlorpropamide
dosage ranges from 50 la 500 mg once daily. Should chlorpropa-
mide-induced hypoglycaemia occur, vigorous treatment is necessary
- often with prolonged glucose infusions - if death or brain
damage is to be avoided.
TABLE I. SULPHONYLUREAS
Trade Dose
Drug name Half-life (mg/d)
First generation
Chlorpropamide Diabinese, ± 36 h 50 - 500
Hypomide
Tolbutamide Rastinon, ± 6h 500-2000
Butamel
Acetohexamide Dimelor ± 5h 250 ·1500
Second generation




Gliclazide Diamicron ± 11 h 40-320
Glipizide Minidiab ± 4h 2,5- 30
The guest editor and author apologise for this error, which has
caused them great concern.
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This error was originally poimed our by Dr G. D. Campbell -
rhank you for sporring it. - Editor
Erratum
Two errors in the caption to the cover picture of the SAMJ of 7
January 1989 have recently been pointed out to us by Dr E. E.
Oertle. Only one of the sperm illustrated is in fact norm3.J.; the one
on the right is distinctly abnormal. Secondly, the slide was given
to us by Dr Oertle and not, as was stated in the caption, by Dr K.
Wiswedel. Dr Oertle also reminds us that the Spermac stain used
is of South Mrican origin (it is in fact his own invention) and that
it is thus most fitting that the illustration should have appeared on
the cover of the SAMJ.
